Mounjaro®
Mounjaro® is GLP-1 medication. It helps to feel full faster through delayed gastric emptying and suppressed glucagon production.
How it works:
Mounjaro® is the dual agonist of GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) and can help you feel fuller and helps to stabilize blood sugar levels. It can help with cravings and appetite and has been found to be effective for weight loss. Mounjaro® is FDA-approved for the treatment of type II diabetes.
How it is taken:
Mounjaro® comes in an injection given at doses which start at 2.5 mg once weekly.
Most common side effects:
Nausea, diarrhea, low appetite, vomiting, stomach upset, and constipation
BLACK BOX WARNING:
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2.
Do not take them if you a history of thyroid cancer.
In studies with rats, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans.
Please notify your doctor right away if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
Do not use alcohol while taking this medication.
If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Mounjaro, as your diabetes medications may need to be adjusted as you lose weight.
Females of reproductive age should use adequate contraception while taking this medication. It is advised to use a non-oral contraceptive method (instead of oral contraceptive) or, if using oral contraception- add a barrier method of contraception 4 weeks after initiation and 4 weeks after dose escalation due to decrease absorption of oral birth control while on GLP-1 drugs.
Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have a history of kidney, liver, or pancreas problems.
Stop using Mounjaro and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious allergic reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Mounjaro if suspected and call 911 .
Drug interactions
Mounjaro can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of low blood sugar (hypoglycemia) is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Mounjaro delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Mounjaro, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted.The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Mounjaro.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to Mounjaro contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.
How it works:
Mounjaro® is the dual agonist of GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) and can help you feel fuller and helps to stabilize blood sugar levels. It can help with cravings and appetite and has been found to be effective for weight loss. Mounjaro® is FDA-approved for the treatment of type II diabetes.
How it is taken:
Mounjaro® comes in an injection given at doses which start at 2.5 mg once weekly.
Most common side effects:
Nausea, diarrhea, low appetite, vomiting, stomach upset, and constipation
BLACK BOX WARNING:
GLP-1s are contraindicated in individuals with a history of medullary thyroid carcinoma, a family history of such, or in patients with multiple endocrine neoplasia syndrome type 2.
Do not take them if you a history of thyroid cancer.
In studies with rats, GLP-1s caused thyroid tumors, including thyroid cancer; it is not known if they will cause thyroid tumors or cancer in humans.
Please notify your doctor right away if you develop trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath.
Do not use alcohol while taking this medication.
If you’re taking diabetes medications, please discuss this with your prescribing doctor before starting Mounjaro, as your diabetes medications may need to be adjusted as you lose weight.
Females of reproductive age should use adequate contraception while taking this medication. It is advised to use a non-oral contraceptive method (instead of oral contraceptive) or, if using oral contraception- add a barrier method of contraception 4 weeks after initiation and 4 weeks after dose escalation due to decrease absorption of oral birth control while on GLP-1 drugs.
Do not take this medication if pregnant, trying to get pregnant or breastfeeding. If you plan to become pregnant, this medication needs to be stopped at least 2 months before trying. This medication may cause fetal harm.
Notify your doctor if you have a history of kidney, liver, or pancreas problems.
Stop using Mounjaro and call your healthcare provider immediately if you have severe stomach or abdomen pain that will not go away, with or without vomiting.
Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including swelling of your face, lips, tongue, or throat; problems breathing or swallowing; severe rash or itching; fainting or feeling dizzy; or very rapid heartbeat.
Serious allergic reactions (e.g., anaphylaxis and angioedema) have been reported. Discontinue Mounjaro if suspected and call 911 .
Drug interactions
Mounjaro can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of low blood sugar (hypoglycemia) is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Mounjaro delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting Mounjaro, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted.The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on Mounjaro.
Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.
To report suspected adverse reactions to Mounjaro contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
In case of emergencies, please call 911 or go to the nearest emergency room.